Pandion Therapeutics, Inc. (PAND) has seen some recent action in the market and its common shares finished trading at $19.21 yesterday. Traders are starting to take notice of PAND as the common shares traded as high as $19.62 and as low as $18.57 in the last trading day.
Pandion Therapeutics, Inc. (PAND) average trading volume is 253.30K. However, in the last trading day Pandion Therapeutics, Inc. (PAND) exchanged 90,341 shares. The First downside support level on PAND is $18.12 and the First resistance level on PAND is $19.72. PAND 50-day moving average is $18.33 and PAND 200-day moving average is $18.33.
Pandion Therapeutics, Inc. (PAND) current performance has been specified by the recent movement in PAND common shares. PAND has performed 4.46% over the past month, PAND has performed – over the past 3 months and PAND has shown – over the past 1 year. Pandion Therapeutics, Inc. (PAND) has a 12 month range of $16.67 to $27.75. Pandion Therapeutics, Inc. (PAND) is trading 15.24% from its 12 month low and -30.78% from its 12 month high. Pandion Therapeutics, Inc. (PAND) is showing a 0.17% short float showing the sum short in the float.
PAND has 29.34M shares outstanding and 20.52M shares in the float. Pandion Therapeutics, Inc. (PAND) presently has a market cap of $563.62M and income of -27.00M. The EPS next quarter for PAND is -0.61 and forecasted EPS next year is 0.00%. The market cap of Pandion Therapeutics, Inc. (PAND) at $563.62M represents how many Traders own shares of PAND and is calculated off the last price ($19.21) of PAND and the sum of shares outstanding (29.34M) with Pandion Therapeutics, Inc. (PAND).
Pandion Therapeutics, Inc. (PAND) has aggregate cash (mrq) of 105.72M, aggregate cash per share (mrq) of 3.58, aggregate debt of PAND remains at 1.81M and aggregate debt/equity (mrq) is 2.01. . Pandion Therapeutics, Inc. (PAND) operational cash flow (ttm) is -15.89M.
PAND is trading 2.45% above (bullish) its SMA20, 4.78% above (bullish) its SMA50 and 4.78% above (bullish) its SMA200.
